Introduction Building on the foundation of The Power of Injectable Autologous Exosomes: Introducing the MCT Metacell Technology System, it becomes clear that the true differentiator in exosome-based therapy is not merely the presence of exosomes—but the origin, integrity, and method of delivery. The MCT framework is specifically engineered around one core principle: that clinically effective regenerative signaling must be both biologically compatible and precisely delivered.